Genetic diversity of integrase (IN) sequences in antiretroviral treatment-naive and treatment-experienced HIV type 2 patients

被引:15
|
作者
Xu, L. [1 ]
Anderson, J. [2 ]
Ferns, B. [3 ]
Cook, P. [1 ]
Wildfire, A. [4 ]
Workman, J. [1 ]
Graham, S. [1 ]
Smit, E. [1 ]
机构
[1] Birmingham Heartlands & Solihull NHS Trust, W Midlands Publ Hlth Lab, Hlth Protect Agcy, Birmingham B9 5SS, W Midlands, England
[2] Homerton Univ Hosp NHS Fdn Trust, London, England
[3] UCL, London, England
[4] Chelsea Westminster Hosp, London, England
关键词
D O I
10.1089/aid.2007.0303
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Two potent integrase inhibitors (IN-Is), raltegravir (RAL, MK-0518) and elvitegravir (EGV, GS-9137), have been shown to be potent inhibitors for HIV-1 and resistance mutations have been identified in HIV-1 clinical trials. In this study, sequences from 11 HIV-2 patients were examined for IN polymorphisms. The primary mutations associated with RAL and EGV resistance were not detected despite the genetic variability among clinical isolates. Our study provides basic information on genotypic susceptibility of HIV-2 to RAL and EGV and supports the suggestion that RAL and EGV could be considered as a new therapeutic option for treating HIV-2-infected patients.
引用
收藏
页码:1003 / 1007
页数:5
相关论文
共 50 条
  • [31] Raltegravir and Abacavir/Lamivudine in Japanese Treatment-Naive and Treatment-Experienced Patients with HIV Infection: a 48-Week Retrospective Pilot Analysis
    Suzuki, Akihito
    Uehara, Yuki
    Saita, Mizue
    Inui, Akihiro
    Isonuma, Hiroshi
    Naito, Toshio
    [J]. JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2016, 69 (01) : 33 - 38
  • [32] Novel Antiretroviral Combinations in Treatment-Experienced Patients with HIV Infection Rationale and Results
    Taiwo, Babafemi
    Murphy, Robert L.
    Katlama, Christine
    [J]. DRUGS, 2010, 70 (13) : 1629 - 1642
  • [33] Genetic contribution to weight gain after initiation of antiretroviral therapy in treatment-naive patients with HIV
    Berenguer, J.
    Jarrin, I.
    Bellon, J.
    Diez, C.
    Jimenez-Sousa, M.
    Navarro-Soler, R.
    Iribarren, J.
    Suarez-Garcia, I.
    Amador, C.
    Curran, A.
    Villarroya, F.
    Domingo, P.
    Resino, S.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 139 - 140
  • [34] Efficacy and safety of sofosbuvir-based therapy for the treatment of chronic hepatitis C in treatment-naive and treatment-experienced patients
    Liu, Xi
    Wang, Yawen
    Zhang, Guanjun
    Li, Na
    Zhu, Qianqian
    Chang, Hongyun
    Han, Qunying
    Lv, Yi
    Liu, Zhengwen
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 44 (02) : 145 - 151
  • [35] Antiretroviral therapy options for treatment-naive patients with HIV-1
    Hedley, Lucy
    Minton, June
    Wallis, Gabriel
    Waters, Laura
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2015, 76 (08) : C122 - C125
  • [36] Efficacy of hepatic arterial infusion chemotherapy between treatment-naive and treatment-experienced patients with advanced hepatocellular carcinoma
    Yu, Hyung-Min
    Kim, Seung-Hun
    Myung, Eun
    Myung, Dea-Seong
    Cho, Sung-Bum
    Lee, Wan-Sik
    Joo, Young-Eun
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 423 - 423
  • [37] THE COMPARATIVE EFFICACY OF TELAPREVIR VERSUS BOCEPREVIR IN TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS
    Diels, J.
    Cure, S.
    Gavart, S.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A266 - A266
  • [38] TREATMENT PERSISTENCE AMONG TREATMENT-EXPERIENCED PEOPLE WITH HIV (PWH) SWITCHING TO INTEGRASE STRAND TRANSFER INHIBITOR (INSTI)-BASED HIV ANTIRETROVIRAL REGIMENS
    Chuo, C. Y.
    Christoph, M. J.
    Zachry, W.
    de Boer, M.
    Chen, M.
    Trom, C.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S318 - S318
  • [39] Two's a Company, Three's a Crowd: A Review of Initiating or Switching to a Two-Drug Antiretroviral Regimen in Treatment-Naive and Treatment-Experienced Patients Living with HIV-1
    Badowski, Melissa
    Perez, Sarah E.
    Silva, David
    Lee, Andrea
    [J]. INFECTIOUS DISEASES AND THERAPY, 2020, 9 (02) : 185 - 208
  • [40] Drug resistance-associated mutations in antiretroviral treatment-naive and -experienced patients in Kuwait
    Chehadeh, W.
    Albaksami, O.
    John, S. E.
    Al-Nakib, W.
    [J]. ACTA VIROLOGICA, 2018, 62 (03) : 259 - 265